Astrazeneca (AZN)

 

Latest News

Stockwatch: Is this a coiled spring or a falling knife?

It's likely private investors are eyeing this mid cap up but sitting on their hands for now. This could be of interest to vigilan...

Tactical Asset Allocator: Emerging market exposure on the up

Emerging markets now make up nearly a third of the Tactical Asset Allocator portfolio. Ceri Jones explains why.

Broker Forecast - Liberum Capital issues a broker note on AstraZeneca PLC

Liberum Capital today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and set its price target at 480...

FTSE slumps as airlines remain weak

Weakness in cigarette sellers and airlines continued to weigh on the FTSE 100, which finished Friday down 0.8% at 7,323. Im...

All News

DateHeadlineSource
22-08-17Stockwatch: Is this a coiled spring or a falling knife?Interactive Investor
21-08-17Tactical Asset Allocator: Emerging market exposure on the upMoney Observer
21-08-17Broker Forecast - Liberum Capital issues a broker note on AstraZeneca PLCStockMarketWire
18-08-17FTSE slumps as airlines remain weakStockMarketWire
18-08-17Tragic terror attack weighs on airlinesStockMarketWire
18-08-17FTSE falls after Barcelona terror attackStockMarketWire
18-08-17AZ-Merck's Lynparza gets US approval for ovarian cancerStockMarketWire
18-08-17Lynparza gets broad FDA approval in ovarian cancerRNS
16-08-17AstraZeneca non-exec to step down StockMarketWire
16-08-17Directorate ChangeRNS
14-08-17Holding(s) in CompanyRNS
10-08-17Publication of a ProspectusRNS
09-08-17Broker views: Drugs and boozeStockMarketWire
09-08-17Broker Forecast - Investec issues a broker note on AstraZeneca PLCStockMarketWire
03-08-17The 10 most popular funds - July 2017Money Observer
02-08-17Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLCStockMarketWire
02-08-17 AZ acalabrutinib submission accepted by US FDAStockMarketWire
02-08-17AZ acalabrutinib submission accepted by US FDARNS
01-08-17Total Voting RightsRNS
01-08-17BTD for AZ's acalabrutinib in mantle cell lymphomaStockMarketWire
01-08-17BTD for AZ's acalabrutinib in mantle cell lymphomaRNS
31-07-17HSBC beats expectations and announces buybackStockMarketWire
31-07-17Mining rally triggered by high commodity pricesStockMarketWire
31-07-17AZ lung cancer drug granted BTD in the USStockMarketWire
31-07-17Imfinzi granted BTD by US FDA for Stage III nsclcRNS
28-07-17Share of the Week: This healthcare small-cap could trebleInteractive Investor
28-07-17Broker Forecast - Beaufort Securities issues a broker note on AstraZeneca PLCStockMarketWire
28-07-17Director Deals - AstraZeneca PLC (AZN)StockMarketWire
28-07-17Director Deals - AstraZeneca PLC (AZN)StockMarketWire
28-07-17Director/PDMR ShareholdingRNS
28-07-17Broker Forecast - Credit Suisse issues a broker note on AstraZeneca PLCStockMarketWire
28-07-17Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLCStockMarketWire
27-07-17FTSE slides lower after AstraZeneca crashStockMarketWire
27-07-17Woodford dealt AstraZeneca blow as share slump 17%Intreractive Investor
27-07-17AstraZeneca plummets on failed MYSTIC trialStockMarketWire
27-07-17AZ's Tagrisso meets primary endpoint in trial StockMarketWire
27-07-17AZ lung cancer drug fails to meet endpoint StockMarketWire
27-07-17AZ reiterates FY guidance StockMarketWire
27-07-17AZ breast cancer drug gets EC approval StockMarketWire
27-07-17Tagrisso significantly improves FLAURARNS

RSS feeds

  • Editorial news feed for LSE:AZN Editorial
  • Regulatory news feed for LSE:AZN Regulatory